Package 52536-180-03

{"route": ["ORAL"], "spl_id": "292b4c82-0b72-5283-e063-6394a90ad2ac", "openfda": {"nui": ["N0000009982", "N0000175877", "N0000175935", "M0028311"], "unii": ["63937KV33D"], "rxcui": ["310155", "310157", "315090"], "spl_set_id": ["e9b5abbb-2952-44ce-8cbb-415d9be23df4"], "pharm_class_cs": ["Macrolides [CS]"], "pharm_class_pe": ["Decreased Sebaceous Gland Activity [PE]"], "pharm_class_epc": ["Macrolide [EPC]", "Macrolide Antimicrobial [EPC]"], "manufacturer_name": ["Wilshire Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, DELAYED RELEASE in 1 BOTTLE (52536-180-03)", "package_ndc": "52536-180-03", "marketing_start_date": "20190722"}, {"sample": false, "description": "100 TABLET, DELAYED RELEASE in 1 BOTTLE (52536-180-10)", "package_ndc": "52536-180-10", "marketing_start_date": "20190722"}], "brand_name": "Erythromycin", "product_id": "52536-180_292b4c82-0b72-5283-e063-6394a90ad2ac", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Decreased Sebaceous Gland Activity [PE]", "Macrolide Antimicrobial [EPC]", "Macrolide [EPC]", "Macrolides [CS]"], "product_ndc": "52536-180", "generic_name": "Erythromycin", "labeler_name": "Wilshire Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Erythromycin", "active_ingredients": [{"name": "ERYTHROMYCIN", "strength": "250 mg/1"}], "application_number": "ANDA062298", "marketing_category": "ANDA", "marketing_start_date": "20190722", "listing_expiration_date": "20261231"}